PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,893,000 | -0.2% | 2,670,761 | +7.2% | 0.02% | 0.0% |
| Q4 2015 | $8,908,000 | -29.5% | 2,491,781 | -0.8% | 0.02% | -33.3% |
| Q3 2015 | $12,633,000 | +37.6% | 2,511,507 | +75.9% | 0.02% | +60.0% |
| Q2 2015 | $9,181,000 | -31.0% | 1,427,935 | -24.5% | 0.02% | -37.5% |
| Q1 2015 | $13,298,000 | -1.8% | 1,890,287 | +7.7% | 0.02% | 0.0% |
| Q4 2014 | $13,535,000 | -6.4% | 1,755,580 | -9.3% | 0.02% | -7.7% |
| Q3 2014 | $14,461,000 | -30.3% | 1,936,010 | -9.7% | 0.03% | -27.8% |
| Q2 2014 | $20,751,000 | +18.6% | 2,143,851 | +1.8% | 0.04% | +16.1% |
| Q1 2014 | $17,498,000 | -6.2% | 2,105,449 | +2.6% | 0.03% | -8.8% |
| Q4 2013 | $18,652,000 | +10.0% | 2,053,039 | -3.5% | 0.03% | +13.3% |
| Q3 2013 | $16,952,000 | +5.1% | 2,126,954 | +1.8% | 0.03% | 0.0% |
| Q2 2013 | $16,128,000 | – | 2,089,055 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |